Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by ronrydellon May 05, 2015 3:44pm

178 Views

Post# 23696530

THOSE WERE THE DAYS!

Currently purging old files from records and see an ETrade account from late 2006-thru Jan 17. 2007.
Price on Dec 7, 2006..$9.40....Price on January 17, 2007...$19.48.

Talk about HUGE daily jumps ..sometime a $1.50 per day at a time. Will this happen again in our future? Will our state of euphoria again be peaked?

in the meantime I'll take the seven to ten cents gains anytime on a daily basis.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"